IFN-gamma and IL-12B polymorphisms in women with cervical intraepithellial neoplasia caused by human papillomavirus

Molecular Biology Reports

Volumn 39, Issue 7, 2012, Pages 7627-7634

  Do Carmo Vasconcelos De Carvalho, Viviane ^a   De MacÊdo, Jamilly Lopes ^a   Albertina Dantas De Lima, Camilla ^a   Da Conceição Gomes De Lima, Maria ^a   De Andrade Heráclio, Sandra ^b   Amorim, Melânia ^b   De Mascena Diniz Maia, Maria ^a   Figueiredo Porto, Ana Lúcia ^a   Eleutério De Souza, Paulo Roberto ^a  

^a UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

^b INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

Author keywords

CIN; HPV; IL 12B; Interferon gamma; Polymorphism

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P40;

ALLELE; ARTICLE; BRAZIL; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; IFNGAMMA GENE; IL12B GENE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84864285621     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1597-9     Document Type: Article

References (47)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17-27. doi:10.1016/j.virol. 2004.03.033 (Pubitemid 38737395)
2. Doorbar J (2005) The papillomavirus life cycle. J Clin Virol 32(Suppl 1):S7-S15. doi:10.1016/j.jcv.2004.12.006 (Pubitemid 40332584)
3. Kanodia S, Fahey LM, Kast WM (2007) Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets 7(1):79-89 (Pubitemid 46345510)
4. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401(1):70-79. doi:10.1016/j.virol. 2010.02.002
5. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518-527. doi:10.1056/NEJMoa 021641348/6/518 (Pubitemid 36159887)
6. Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J, Hughes TK, Stisser K, Konig R, Tyring SK (2004) Nested PCR with the PGMY09/11 and GP5(?)/6(?) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 122(1):87-93. doi:10.1016/j.jviromet.2004.08.007 (Pubitemid 39370054)
7. Bhat P, Mattarollo SR, Gosmann C, Frazer IH, Leggatt GR (2011) Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunol Rev 239(1):85-98. doi: 10.1111/j.1600-065X.2010.00966.x
8. Brasil (2010) Ministério da Saúde. Instituto Nacional do Câncer. http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/ colo-utero/definicao. Accessed 25 Jan 2011
9. von Linsingen R, Bompeixe EP, Maestri CA, Carvalho NS, da Graca Bicalho M (2009) IFNG (?874 T/A) polymorphism and cervical intraepithelial neoplasia in Brazilian women. J Interferon Cytokine Res 29(5):285-288. doi:10.1089/jir.2008. 0081
10. Han SS, Cho EY, Lee TS, Kim JW, Park NH, Song YS, Kim JG, Lee HP, Kang SB (2008) Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women. Eur J Obstet Gynecol Reprod Biol 140(1):71-75. doi:10.1016/j. ejogrb.2008.02.007
11. Abbas AK, Lichtman AH, Andrew H, Pillai S (2008) Imunologia celular e molecular, 6th edn. Elsevier, São Paulo
12. Farzaneh F, Roberts S, Mandal D, Ollier B, Winters U, Kitchener HC, Brabin L (2006) The IL-10-1082G polymorphism is associated with clearance of HPV infection. BJOG 113(8):961-964. doi:10.1111/j.1471-0528.2006.00956.x (Pubitemid 44086926)
13. Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107(10):4101-4108. doi:10.1182/blood-2005-10-4160 (Pubitemid 43726819)
14. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28(3):704-712. doi: 10.1093/carcin/bgl200 (Pubitemid 46523368)
15. Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P (2007) Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 109(12):5439-5446. doi: 10.1182/blood-2006-11-058040 (Pubitemid 46890567)
16. Nieters A, Yuan JM, Sun CL, Zhang ZQ, Stoehlmacher J, Gov-indarajan S, Yu MC (2005) Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103(4):740-748. doi:10.1002/cncr.20842 (Pubitemid 40216402)
17. Navaglia F, Basso D, Zambon CF, Ponzano E, Caenazzo L, Gallo N, Falda A, Belluco C, Fogar P, Greco E, Di Mario F, Rugge M, Plebani M (2005) Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals. J Med Genet 42(6):503-510. doi:10.1136/jmg.2004.022723 (Pubitemid 40847240)
18. Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, Shen H, Hu Z (2009) Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res 15(1):400-405. doi:10.1158/1078-0432.CCR-08-1829
19. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61(9):863-866. doi:10.1016/j.humimm.2010.03. 008
20. Vallinoto AC, Graca ES, Araujo MS, Azevedo VN, Cayres-Vallinoto I, Machado LF, Ishak MO, Ishak R (2010) IFNG ?874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. Hum Immunol 71(7):692-696. doi:10.1016/j.humimm.2010.03.008
21. Torres OA, Calzada JE, Beraun Y, Morillo CA, Gonzalez A, Gonzalez CI, Martin J (2010) Role of the IFNG ?874T/A polymorphism in Chagas disease in a Colombian population. Infect Genet Evol 10(5):682-685. doi:10.1016/j.meegid. 2010. 03.009
22. Urbanowicz I, Mazur G, Stacherzak-Pawlik J, Bogunia-Kubik K, Wrobel T, Wozniak M, Kuliczkowski K (2010) IFN gamma gene polymorphism may contribute to the susceptibility to CLL. Pathol Oncol Res 16(2):213-216. doi:10.1007/s12253- 009-9209-2
23. Yu H, Zhu QR, Gu SQ, Fei LE (2006) Relationship between IFN-gamma gene polymorphism and susceptibility to intrauterine HBV infection. World J Gastroenterol 12(18):2928-2931 (Pubitemid 43805466)
24. Mant C, Kell B, Best JM, Cason J (1997) Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types-6, -11, -16, -18, -31 and-33. J Virol Methods 66(2):169-178 (Pubitemid 27305367)
25. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV (1999) ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 7(2):127-128 (Pubitemid 29472075)
26. Reynard MP, Turner D, Navarrete CV (2000) Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleu-kin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 27(4):241-249
27. Sousa CS (2003) Comparação das técnicas de SSCP, DS-PCR, PCR-RFLP para detecção de mutação no gene mitocondrial 16s RRNA em populações de Melipona Rufiventris. Biosci J Uber-lândia 19:65-70
28. Marcos M, Pastor I, Gonzalez-Sarmiento R, Laso FJ (2009) Common polymorphisms in interleukin genes (IL4, IL6, IL8 and IL12) are not associated with alcoholic liver disease or alcoholism in Spanish men. Cytokine 45(3):158-161. doi:10.1016/j. cyto.2008.11.003
29. Poli F, Nocco A, Berra S, Scalamogna M, Taioli E, Longhi E, Sirchia G (2002) Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur J Immunogenet 29(3):237-240 (Pubitemid 34621798)
30. Gangwar R, Pandey S, Mittal RD (2009) Association of inter-feron-gamma ?874A polymorphism with the risk of developing cervical cancer in north-Indian population. BJOG 116(12): 1671-1677. doi:10.1111/j.1471-0528.2009.02307.x
31. Govan VA, Carrara HR, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL (2003) Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog 2(1):3. doi:10.1186/1477- 3163-2-3 (Pubitemid 38751380)
32. Pao CC, Yao DS, Lin CY, Lee SC, Su HT, Lin SC (1996) Genomic aberrations of human papillomavirus recovered from cervical cancers. Biochem Biophys Res Commun 222(1):116-120. doi: 10.1006/bbrc.1996.0707 (Pubitemid 26152214)
33. Kordi Tamandani MK, Sobti RC, Shekari M, Mukesh M, Suri V (2008) Expression and polimorphism of IFN-gamma gene in patients with cervical cancer. Exp Oncol 30(3):224-229
34. Matos GI, Covas Cde J, Bittar Rde C, Gomes-Silva A, Marques F, Maniero VC, Amato VS, Oliveira-Neto MP, Mattos Mda S, Pirmez C, Sampaio EP, Moraes MO, Da-Cruz AM (2007) IFNG ?874T/A polymorphism is not associated with American tegu-mentary leishmaniasis susceptibility but can influence Leish-mania induced IFN-gamma production. BMC Infect Dis 7:33. doi:10.1186/1471-2334-7-33 (Pubitemid 46863629)
35. Tangwattanachuleeporn M, Sodsai P, Avihingsanon Y, Won-gpiyabovorn J, Wongchinsri J, Hirankarn N (2007) Association of interferon-gamma gene polymorphism (?874A) with arthritis manifestation in SLE. Clin Rheumatol 26(11):1921-1924. doi: 10.1007/s10067-007-0699-6 (Pubitemid 47516976)
36. Lai HC, Chang CC, Lin YW, Chen SF, Yu MH, Nieh S, Chu TW, Chu TY (2005) Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesis. Int J Cancer 113(5):712-718. doi:10.1002/ijc.20637 (Pubitemid 40101251)
37. Hoffmann TW, Halimi JM, Buchler M, Velge-Roussel F, Al-Najjar A, Marliere JF, Lebranchu Y, Baron C (2009) Impact of a polymorphism in the IL-12p40 gene on the outcome of kidney transplantation. Transplant Proc 41(2):654-656. doi:10.1016/j. transproceed.2008.12.002
38. Zafra G, Morillo C, Martin J, Gonzalez A, Gonzalez CI (2007) Polymorphism in the 3′ UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect 9(9):1049-1052. doi:10.1016/j.micinf.2007.04.010 (Pubitemid 47299211)
39. Morahan G, Boutlis CS, Huang D, Pain A, Saunders JR, Hobbs MR, Granger DL, Weinberg JB, Peshu N, Mwaikambo ED, Marsh K, Roberts DJ, Anstey NM (2002) A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun 3(7):414-418. doi: 10.1038/sj.gene.6363909 (Pubitemid 41656540)
40. Phawong C, Ouma C, Tangteerawatana P, Thongshoob J, Were T, Mahakunkijcharoen Y, Wattanasirichaigoon D, Perkins DJ, Khusmith S (2010) Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adults. Immunogenetics 62(6):345-356. doi:10.1007/s00251-010-0439-y
41. Muller-Steinhardt M, Fricke L, Muller B, Ebel B, Kirchner H, Hartel C (2004) Cooperative influence of the interleukin-6 promoter polymorphisms-597, -572 and-174 on long-term kidney allograft survival. Am J Transplant 4(3):402-406 (Pubitemid 38282296)
42. Selvaraj P, Alagarasu K, Harishankar M, Vidyarani M, Nisha Rajeswari D, Narayanan PR (2008) Cytokine gene polymorphisms and cytokine levels in pulmonary tuberculosis. Cytokine 43(1):26-33. doi:10.1016/j.cyto.2008.04.011
43. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G (2002) A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 3(7):419-423. doi:10.1038/sj.gene.6363919 (Pubitemid 41656541)
44. Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stef-anon B, Venzon DJ, Shearer GM, De Palo G, Clerici E (1997) Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89(3):245-250 (Pubitemid 27073762)
45. El-Sherif AM, Seth R, Tighe PJ, Jenkins D (2001) Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J Pathol 195(2):179-185. doi:10.1002/path.929 (Pubitemid 32899026)
46. Peghini BC (2009) Perfil da resposta imune local em pacientes com lesão intraepitelial cervical de baixo grau, alto grau e neo-plasia invasiva. Universidade Federal do Triângulo Mineiro, Uberaba
47. Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Par-miani G, Anichini A (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13(16):4677-4685. doi: 10.1158/1078-0432.CCR-07- 0776 (Pubitemid 47294773)